- Aimedbio receives equity investment from the "Life Science Fund", an investment fund created by Samsung Biologics, Samsung C&T, and Samsung Bioepis.
- It is Samsung's fourth investment through the "Life Science Fund", but the first case as domestic investment.
- They will be collaborating on ADC toolbox co-development and CDO business of AMB001, a KDDF grant-receiving platform.